Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Daniel Nickerson
WARNING LETTER
•Daniel Nickerson•October 23, 2014

FDA WARNING_LETTER - Daniel Nickerson - October 23, 2014

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On October 8 and 23, 2014, the FDA investigated Daniel W. Nickerson Farm, a dairy operation in Scio, New York. The investigation revealed violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) related to adulterated animals offered for slaughter and improper drug use.

Specifically, on May 19, 2014, two bob veal calves sold for slaughter contained neomycin residues in kidney tissue at 16.11 ppm and 19.29 ppm, respectively. On June 2, 2014, a third bob veal calf sold for slaughter had 16.8 ppm of neomycin in its kidney. The FDA tolerance for neomycin in cattle kidney is 7.2 ppm, but there is no acceptable level for neomycin in bob veal calves when using the specific medicated feed supplement (b)(4) (neomycin sulfate and oxytetracycline hydrochloride). This caused the food to be adulterated under section 402(a)(2)(C)(ii) of the FD&C Act.

The investigation also found that animals were held under insanitary conditions, likely leading to medicated animals with harmful drug residues entering the food supply, violating section 402(a)(4) of the FD&C Act. This was evidenced by a failure to maintain complete treatment records.

Furthermore, the medicated feed supplement (

Company
Daniel Nickerson
Inspection Date
October 23, 2014
Product Type
Drugs
Office
New York District Office
Person
  • Ronald M. Pace (Program Director)
Open in Dashboard

ID · cee26f5c-af1f-40c4-b12d-f9704b93039c

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 U.C.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(a)21 CFR 530.11(c)21 U.S.C. 351(a)(5)21 U.S.C. 351(a)(6)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.